Long Term Follow-Up Gene Therapy Study for XLRP RPGR
Long Term Follow-Up Study of Participants Following an Open Label, Multi-Centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-Associated Virus Vector (AAV2-RPGR) for Gene Therapy of Adults and Children With X-Linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR) Long Term Follow-Up Study of Participants Following an Open Label, Multi-Centre, Phase I/II Dose Esc ...